KCAS Bio is a leading CRO with 45 years of experience supporting pharma and biotech sponsors from discovery through registration.
It has supported 300+ FDA-approved drugs, developed 5,000+ assays, and completed dozens of FDA audits with no major findings.
With locations in the US and Europe and an alliance in Australia, KCAS Bio delivers global bioanalytical, biomarker, immunogenicity, assay, kitting, and sample management services.